Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cerebral Therapeutics Inc.

Headquarters: Aurora, CO, United States of America
Year Founded: 2010
Status: Private

BioCentury | Jan 27, 2023
Management Tracks

Hall becomes CEO of Innocoll

Plus: Henderson named CFO at Apogee, and updates from Cerebral and Element
BioCentury | Jun 29, 2022
Product Development

June 28 Quick Takes: Roivant, Pfizer create start-up to house TYK2/JAK1 program

Plus Jazz’s Sativex misses and updates from Sanofi, Spero, SonALAsense and more
BioCentury | Aug 4, 2021
Management Tracks

Arbuckle becomes COO at Vertex

Plus: GlycoMimetics names Semerjian as King’s successor, plus updates from Pieris, Assembly and more
BioCentury | Nov 12, 2020
Management Tracks

ObsEva, Korro bring in new CEOs; plus Cerebral, Spartan, Apnimed and Micronoma

Women’s reproductive health company ObsEva S.A. (SIX:OBSN; NASDAQ:OBSV) hired Brian O’Callaghan as CEO , effective Dec. 1. He succeeds Ernest Loumaye, who will
BioCentury | Dec 14, 2015
Company News

Flowonix Medical, Cerebral Therapeutics deal

Items per page:
1 - 10 of 10